Singapore designs preclinical model to strategise treatment for a genetic kidney disease

Therapeutics |  News | 0 Comment | 10 Mar, 2022

Scientists from Duke-NUS Medical School, Singapore have designed a treatment strategy for genetic kidney disease ‘...Read more

Japan uses supercomputer and AI to shed light on drug resistance in cancer treatment

Therapeutics |  News | 0 Comment | 07 Mar, 2022

Japan-based Fujitsu and the Tokyo Medical and Dental University (TMDU) have announced a new technology that uses artific...Read more

IASO Bio strengthens manufacturing of CAR-T cell therapy products in China

Therapeutics |  News | 0 Comment | 02 Mar, 2022

IASO Biotherapeutics, a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing i...Read more

Thermo Fisher calls for proposals in 'Cancer Molecular Profiling' research

Therapeutics |  News | 0 Comment | 01 Mar, 2022

As part of its ongoing commitment to support clinical oncology research, US-based Thermo Fisher Scientific is calling fo...Read more

Korea-based GI Innovation strengthens focus on next-gen innovative immuno-oncology

Therapeutics |  News | 0 Comment | 28 Feb, 2022

GI Innovation, based in South Korea, has signed a biomarker joint research MoU with CellKey, a Glycoprotein biomarker de...Read more

Korea develops electronic skin that can feel in real time

Therapeutics |  News | 0 Comment | 23 Feb, 2022

A research team at Pohang University of Science and Technology in South Korea, in collaboration with the Department...Read more

Japan proposes framework for conducting ethical research on brain organoids

Therapeutics |  News | 0 Comment | 23 Feb, 2022

Researchers from Kobe University and Kyoto University’s Institute for the Advanced Study of Human Biology (WPI-ASH...Read more

Australia invests $23 M for preventive health projects

Therapeutics |  News | 0 Comment | 21 Feb, 2022

The Australia government is investing $23 million in three Victorian health projects that will help prevent chronic dise...Read more

Hong Kong finds new inflammatory activation pathway in blood vessels after SARS-CoV-2 infection

Therapeutics |  News | 0 Comment | 18 Feb, 2022

A study led by The Chinese University of Hong Kong's (CUHK) Faculty of Medicine (CU Medicine) and the LKS Faculty of Med...Read more

Singapore discovers unique lysin capable of killing deadly multi drug-resistant bacteria

Therapeutics |  News | 0 Comment | 17 Feb, 2022

Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-M...Read more

Japan fabricates polymer-DNA gel that could be used in tissue regeneration and robotics

Therapeutics |  News | 0 Comment | 17 Feb, 2022

Scientists at Hokkaido University in Japan have made a tuneable, elastic and temperature-sensitive g...Read more

Singapore finds why Alzheimer’s disease females face faster memory decline

Therapeutics |  News | 0 Comment | 16 Feb, 2022

A joint study by Nanyang Technological University, Singapore (NTU Singapore) and National University of Singapore (NUS) ...Read more

Japan discovers host immune-dependent novel anti-coronavirus antibody

Therapeutics |  News | 0 Comment | 16 Feb, 2022

The National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), in partnership with Shionogi & Co....Read more

Genetic research in NZ offers hope for preventing Parkinson’s disease

Therapeutics |  News | 0 Comment | 15 Feb, 2022

There’s new hope for treating Parkinson’s disease with the publication of groundbreaking genetic research fr...Read more

Singapore develops method for creating promising new sulphur-based medicines

Therapeutics |  News | 0 Comment | 15 Feb, 2022

A key technical challenge in creating new sulphur-based medicines has been overcome by scientists at Nanyang Techno...Read more

Indian startup Bugworks Research secures $18M to advance work in AMR

Therapeutics |  News | 0 Comment | 09 Feb, 2022

Indian startup Bugworks Research, with operations in US and Australia, has announced the financing of $18M Ser...Read more

Korea's Bridge Biotherapeutics to uncover new druggable sites in oncology, immunology

Therapeutics |  News | 0 Comment | 08 Feb, 2022

Bridge Biotherapeutics, a South Korean clinical-stage biotechnology company focused on developing novel drugs for inflam...Read more

US-India collaborate for development, commercialisation of first-in-class bone health drugs

Therapeutics |  News | 1 Comment | 03 Feb, 2022

CSIR-Central Drug Research Institute (CDRI), Lucknow, one of the premier drug research institutions in India and Aveta B...Read more